Long-term analysis of colonic aberrant crypt formation after treatment of Sprague-Dawley rats with azoxymethane

Teratogenesis Carcinogenesis and Mutagenesis

Volumn 18, Issue 4, 1998, Pages 183-197

  Davies, M J ^a   Rumsby, P C ^a,b  

^a BIBRA International ^*  (United Kingdom)

^b BIBRA INTERNATIONAL   (United Kingdom)

Author keywords

Aberrant crypt foci; Colon cancer; Multistage disease; Oncogene; Tumour suppressor genes

Indexed keywords

AZOXYMETHANE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASE MISPAIRING; CARCINOGENICITY; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; ECTOPIC TISSUE; INTESTINE CRYPT; NONHUMAN; ONCOGENE K RAS; PRIORITY JOURNAL; RAT; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ANIMALS; AZOXYMETHANE; CARCINOGENS; COLONIC NEOPLASMS; MALE; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PRECANCEROUS CONDITIONS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0031739411     PISSN: 02703211     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6866(1998)18:4<183::AID-TCM4>3.0.CO;2-D     Document Type: Article

References (37)

1. McLellan EA, Bird RP: Aberrant crypts: potential preneoplastic lesions in the murine colon. Cancer Res 48:6187-6192, 1988.
2. Pretlow TP, O'Riordan MA, Somich GA, Amini SB, Pretlow TG: Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 13:1509-1512, 1992.
3. Magnuson BA, Carr I, Bird RP: Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Cancer Res 53:4499-4504, 1993.
4. Su L-K, Kinzler KW, Vogelstein B, Preisinger AC, Moser AR, Luongo C, Gould KA, Dove WF: Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256:668-670, 1992.
5. Jacoby RF, Llor X, Terry B-B, Davidson NO, Brasitus TA: Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa. J Clin Invest 87:624-630, 1992.
6. Jacoby RF, Alexander RJ, Raicht RF, Brasitus TA: K-ras oncogene mutations in rat colon tumors induced by N-methyl-N-nitrosourea. Carcinogenesis 51:45-49, 1992.
7. Rumsby PC, Davies MJ, Evans JG: Screening for p53 mutations in C3H/He mouse liver tumors derived spontaneously or induced with diethylnitrosamine or phenobarbitone. Mol Carcinogen 9:71-75, 1994.
8. Verlaan-de Vries M, Bogaard ME, van den Elst H, van Boom JH, van der Eb AJ, Bos JL: A dot-blotting procedure for mutated ras oncogenes using synthetic oligodeoxynucleotides. Gene 50:313-320, 1986.
9. Rumsby PC, Barrass NC, Phillimore HE, Evans JC: Analysis of the Ha-ras oncogene in C3H/He mouse liver tumours derived spontaneously or induced with diethylnitrosamine or phenobarbitone. Carcinogenesis 12:2331-2336, 1991.
10. Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilbertson J, Foster C, Marshall CM: Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 51:3497-3502, 1991.
11. Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S, Aoki T, Miki Y, Mori T, Nakamura Y: Somatic mutation of the APC gene in colorectal cancer: mutation cluster region in the APC gene. Hum Mol Genet 1:229-233, 1992.
12. Kakiuchi H, Watanabe M, Ushijima T, Toyota M, Imai K, Weisberger JH, Sugimura T, Nagao M: Specific 5′-GGGA-3′ mutation of the Ape gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Proc Natl Acad Sci USA 92:910-914, 1995.
13. Bird RP, McLellan EA, Bruce WR: Aberrant crypts, putative precancerous lesions, in the study of the role of diet in the aetiology of colon cancer. Cancer Surv 8:189-200, 1989.
14. Bruce WR, Archer MC, Corpet DE, Medline A, Minkin S, Stamp D, Yin Y, Zhang X-M: Diet, aberrant crypt foci and colorectal cancer. Mutat Res 290:111-118, 1993.
15. Pretlow TP, Barrow BJ, Ashton WS, O'Riordan MA, Pretlow TG, Jurisek JA, Stellato TA: Aberrant crypts: putative preneoplastic foci in human colon mucosa. Cancer Res 51:1564-1567, 1991.
16. Shivapurkar N, Tang Z-C, Alabaster O: The effect of high-risk and low-risk diets on aberrant crypt and colonic tumor formation in Fischer-344 rats. Carcinogenesis 13:887-890, 1992.
17. Alabaster O, Tang Z-C, Frost A, Shivapurkar N: Effect of β-carotene and wheat bran fiber on colonic aberrant crypt and tumor formation in rats exposed to azoxymethane and high dietary fat. Carcinogenesis 16:127-132, 1995.
18. Qin X, Zarkovic M, Nakatsuru Y, Arai M, Oda H, Ishikawa T: DNA adduct formation and assessment of aberrant crypt foci in vivo in the rat colon mucosa after treatment with N-methyl-N-nitrosourea. Carcinogenesis 15:851-855, 1994.
19. Shpitz B, Hay K, Medline A, Bruce B, Vivona A, Gallinger S, Bull S, Stern H: Aberrant cypt foci: early markers of malignancy in rat colon Carcinogenesis. Proc Am Assoc Cancer Res 34:115, 1993.
20. Carter JW, Lancaster HK, Hardman WE, Cameron LL: Distribution of intestine-associated lymphoid tissue, aberrant crypt foci and tumors in the large bowel of 1,2-dimethylhydrazine-treated mice. Cancer Res 54:4304-4307, 1994.
21. McLellan EA, Medline A, Bird RP: Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: putative preneoplastic lesions. Cancer Res 51:5270-5274, 1991.
22. Bannasch P: Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia. Carcinogenesis 7:689-695, 1986.
23. Bird RP: Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 93:55-71, 1995.
24. Stopera SA, Murphy LC, Bird RP: Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer. Carcinogenesis 13:2081-2085, 1992.
25. Singh J, Kulkarni N, Kelloff G, Reddy BS: Modulation of azoxymethane-induced mutational activation of ras protooncogenes by chemopreventive agents in colon Carcinogenesis. Carcinogenesis 15:1317-1323, 1994.
26. Llor X, Jacoby RF, Terry B-B, Davidson NO, Surrin MD, Brasitus TA: K-ras mutations in 1,2-dimethylhydrazine-induced colonic tumors: effects of supplemental dietary calcium and vitamin D deficiency. Cancer Res 51:4305-4309, 1991.
27. Pretlow LP, Brasitus TA, Fulton NC, Cheyer C, Kaplan EL: K-ras mutations in putative preneoplastic lesions in human colon. J Natl Cancer Inst 85:2004-2007, 1993.
28. Rumsby PC, Evans JG, Phillimore HE, Carthew P, Smith AG: Search for Ha-ras codon 61 mutations in liver tumours caused by hexachlorobenzene and Aroclor 1254 in C57BL/10ScSn mice with iron overload. Carcinogenesis 13:1917-1920, 1992.
29. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW: APC mutations occur early during colorectal tumorigenesis. Nature 359:235-237, 1992.
30. Jen J, Powell SM, Papadopoulos N, Smith K, Hamilton SR, Vogelstein B, Kinzler KW: Molecular determinants of dysplasia in colorectal lesions. Cancer Res 54:5523-5526, 1994.
31. Smith AJ, Stern HS, Penner M, Hay K, Mitri A, Bapat BV, Gallinger S: Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 54:5527-5530, 1994.
32. Kikuchi-Yanoshita R, Konishi M, Ito S, Seki M, Tanaka K, Maeda Y, Iino H, Fukajama M, Koike M, Mori T, Sakuraba H, Fukunari H, Iwama T, Miyaki M: Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-adenomatous polyposis patients. Cancer Res 52:3965-3971, 1992.
33. Okamoto M, Ohtsu H, Miyaki M, Yonekawa H: No allelic loss at the p53 locus in 1,2-dimethylhydrazine-induced mouse colon tumors: PCR-SSCP analysis with sequence-tagged microsatellite site primers. Carcinogenesis 14:1483-1486, 1993.
34. Shivapurkar N, Belinsky SA, Wolf DC, Tang Z, Alabaster O: Absence of p53 gene mutations in rat colon carcinomas induced by azoxymethane. Cancer Lett 96:63-70, 1995.
35. Makino H, Ushijima T, Kakiuchi H, Onda M, Ito N, Sugimura T, Nagao M: Absence of p53 mutations in rat colon tumors induced by 2-amino-6-methyl-dipyride[1,2-a:3′,2′-d]imidazole, 2-amino-2O-methylimidazo[4,5-f]quinoline or 2-amino-1-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn J Cancer Res 85:510-514, 1994.
36. Donehower LA, Harvey M, Slagle BL, McArther MJ, Montgomery CA, Butel JS, Bradley A: Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356:215-221, 1992.
37. Moen CJ, Groot PC, Hart AA, Snoek M, Demant P: Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from genes known to be somatically mutated in colon carcinoma. Proc Natl Acad Sci USA 93:1082-1086, 1996.